Loading clinical trials...

Managing Transient Neurologic Episodes in Surgery for Moyamoya Disease | Clinical Trials | Clareo Health

RECRUITINGNCT06880341

Managing Transient Neurologic Episodes in Surgery for Moyamoya Disease

The goal of this study is to study the incidence of post-operative Transient Neurologic Events (TNEs) within 30 days postoperatively, as assessed by clinical neurological scales, binned by week. Colle...

Lead sponsor: Stanford University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Jinendra Ekanayake

CONTACT

650-660-1266 [email protected]

Anthony Bet

CONTACT

[email protected]

Related studies

COMPLETED

Super-resolution Clinical Brain Ultrasound

NCT05785598 · Ischemic Stroke, Moya Moya Disease

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 28, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment88

Start dateMay 2025

Last updatedMay 28, 2025

Condition

Moya Moya Disease

Locations shown

Stanford University Hospital

Palo Alto, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 28, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions